loadpatents
Patent applications and USPTO patent grants for Valtuena; Jesus Prieto.The latest application filed is for "adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells".
Patent | Date |
---|---|
Adenovirus/Alphavirus Hybrid Vector for the Effective Administration and Expression of Therapeutic Genes in Tumour Cells App 20070224170 - Qian; Cheng ;   et al. | 2007-09-27 |
Method for the treatment of skin fibrosis and suitable compositions for such treatment App 20070207965 - Cuesta; Francisco Borras ;   et al. | 2007-09-06 |
Peptides with the capacity to bind to transforming growth factor b1 (tgf-b1) App 20070142275 - Delas Herrerias; Javier Dotor ;   et al. | 2007-06-21 |
Method of reversible inhibition of gene expression by means of modified ribonucleoproteins App 20050043261 - Alonso, Purificacion Fortes ;   et al. | 2005-02-24 |
Use of cardiotrophin in liver diseases App 20040224888 - Abajo, Matilde Bustos De ;   et al. | 2004-11-11 |
Method of treatment using a therapeutic combination of .alpha. interferon and free radical scavengers Grant 5,830,455 - Valtuena , et al. November 3, 1 | 1998-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.